glp 1's GLP-1 receptor agonists GLP-1s for Weight Loss: What
Description
World Health Organization
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing
If you're not, this isn't a reason to start one
However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors
It may also be important to monitor levels of certain vitamins and minerals
In 2025 we saw label expansions for semaglutide and tirzepatide, underscoring a trend toward whole-body health
